Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Trojano

Showing results (191-200 of 342) with videos related to

Pageof 35
Sort By:
Stem Cell Research & Therapy|January 17, 2019
DP71 and SERCA2 alteration in human neurons of a Duchenne muscular dystrophy patientSimona Ruggieri, Luigi Viggiano, Tiziana Annese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendationsWallace J Brownlee, Christian Wolf, Hans-Peter Hartung, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire)Silvy Pilotto, Jessica Gencarelli, Stefania Bova, et al.
Journal of Medical Internet Research|October 6, 2021
Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based SurveyTjalf Ziemssen, Gavin Giovannoni, Enrique Alvarez, et al.
Journal of Neuroimmunology|May 12, 2005
Osteopontin gene haplotypes correlate with multiple sclerosis development and progressionAnnalisa Chiocchetti, Cristoforo Comi, Manuela Indelicato, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 22, 2022
Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying TherapiesTjalf Ziemssen, Virender Bhan, Jeremy Chataway, et al.
Toxins|January 20, 2023
Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life StudyIlenia Corbelli, Angela Verzina, Ilaria Leone De Magistris, et al.
Neurology|September 14, 2014
Neuropsychological features in childhood and juvenile multiple sclerosis: five-year follow-upMaria P Amato, Benedetta Goretti, Angelo Ghezzi, et al.
Neurology|July 29, 2016
History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohortAmandine Benoit, Françoise Durand-Dubief, Maria-Pia Amato, et al.
Journal of Neurology|October 27, 2004
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosisGiovanni Savettieri, Demetrio Messina, Virginia Andreoli, et al.
Pageof 35

Showing results (191-200 of 342) with videos related to

Sort By:
Pageof 35
Stem Cell Research & Therapy|January 17, 2019
DP71 and SERCA2 alteration in human neurons of a Duchenne muscular dystrophy patientSimona Ruggieri, Luigi Viggiano, Tiziana Annese, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 24, 2022
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendationsWallace J Brownlee, Christian Wolf, Hans-Peter Hartung, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 6, 2021
Etiological research in pediatric multiple sclerosis: A tool to assess environmental exposures (PEDiatric Italian Genetic and enviRonment ExposurE Questionnaire)Silvy Pilotto, Jessica Gencarelli, Stefania Bova, et al.
Journal of Medical Internet Research|October 6, 2021
Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based SurveyTjalf Ziemssen, Gavin Giovannoni, Enrique Alvarez, et al.
Journal of Neuroimmunology|May 12, 2005
Osteopontin gene haplotypes correlate with multiple sclerosis development and progressionAnnalisa Chiocchetti, Cristoforo Comi, Manuela Indelicato, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 22, 2022
Secondary Progressive Multiple Sclerosis: A Review of Clinical Characteristics, Definition, Prognostic Tools, and Disease-Modifying TherapiesTjalf Ziemssen, Virender Bhan, Jeremy Chataway, et al.
Toxins|January 20, 2023
Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life StudyIlenia Corbelli, Angela Verzina, Ilaria Leone De Magistris, et al.
Neurology|September 14, 2014
Neuropsychological features in childhood and juvenile multiple sclerosis: five-year follow-upMaria P Amato, Benedetta Goretti, Angelo Ghezzi, et al.
Neurology|July 29, 2016
History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohortAmandine Benoit, Françoise Durand-Dubief, Maria-Pia Amato, et al.
Journal of Neurology|October 27, 2004
Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosisGiovanni Savettieri, Demetrio Messina, Virginia Andreoli, et al.
Pageof 35